Improvement in the capillarity of the left ventricular wall of stroke- prone spontaneously hypertensive rats following angiotensin II receptor blockade

Clinical and Experimental Hypertension

Volumn 21, Issue 4, 1999, Pages 441-452

  Xie, Zonglin ^a   Gao, Ming ^a   Togashi, Hiroko ^b   Saito, Hideya ^b   Koyama, Tomiyasu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor blockade; Arteriolar and venular capillary portions; Capillarity; Left ventricle; SHRSP

Indexed keywords

CANDESARTAN HEXETIL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY FLOW; DRUG EFFECT; HEART LEFT VENTRICLE WALL; HEART MUSCLE PERFUSION; HYPERTENSION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

EID: 0032959098     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909068675     Document Type: Article

References (21)

1. Koyama T, Gao M, Mikuni M, Horimoto M. Experimental hypertension and angiotensin converting enzyme blocker on myocardial hypertrophy and capillary blood vessels. Jap Pharmacol Then. 1994;22:4643-4646. (in Japanese).
2. Xie Z, Gao M, Horimoto M, Togashi H, Saito H, Koyama T. Rearrangement of the ventricular capillary network in stroke-prone spontaneously hypertensive rats (SHRSP) following a late start of treatment with an angiotensin converting enzyme blocker temocapril. Jap Heart J 1998; 39(5): (in press).
3. Gohlke P, Linz W, Schoelkens BA,Kuwar I, Bartenbach s, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 1994;23:411-418.
4. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type IA) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993;73:439-447.
5. Yamazaki T, Komuro I, Kudoh S, et al. angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 1995;77:258-265.
6. Nishikimi T, Tani T, Ohmura T, et al. Angiotensin II type-1 receptor antagonist as well as angiotensin converting enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats. Jap Circ J. 1995;59:754-761.
7. Mizuno K, Nimura M, Tani M, Saito I, Sanada H, Takahashi M, Okazaki K, Yamaguchi M, Fukuchi S. Hypotensive activity of TCV116, a newly developed angiotensin II receptor antagonist in spontaneously hypertensive rats. Life Sci. 1992;51:183-187.
8. Lojda Z: Studies on dipeptidyl(amino)peptidase IV (glycyl-proline naphthylamidase). II blood vessels. Histochemistry 1979;59:153-166.
9. Batra S, Rakusan K: Geometry of capillary networks in hypertrophied rat heart. Microvasc Res 1991; 41:29-40.
10. Batra S, Rakusan K: Capillary network geometry during postnatal growth in rat hearts. Am J Physiol 1992;262: H636-H640.
11. Koyama T, Gao M, Uede T, Batra S, Itoh K, Ushiki T, Abe K: Different enzyme activities in coronary capillary endothelial cells. Oxygen Transport to Tissue XVIII, ed. by Nemoto EM& La Manna P, Plenum Publ Co. New York, 1997, 359-364.
12. Koyama T, XIE Z, GAO M, SUZUKI J, BATRA S, Adaptive changes in the capillary network in the left ventricle of rat heart. Jap J Physiol 1998;48:229-241.
13. Hoofd L, Turek Z, Kubat K, Ringanalda BEM, Kazda S: Variability of intercapillary distance estimated on histological sections of rat heart. In: Oxygen Transport to Tissues VIII, ed by Kreuzer F, Cain SM, Goldstick TK, Plenum Publ Co. New York, 1985, 239-247.
14. Minami M, Sano M, Togashi H, Sakura H, Saito H. Stroke-related plasma noradrenaline, angiotensin II, arginine-vasopressin, and serotonin concentrations in stroke-prone spontaneously hypertensive rats. Progress in Hypertension. 1988;1:89-114.
15. Koyama T, Gao M, Batra S, Togashi H, Saito H. Myocyte hypertrophy and capillarization in spontaneously hypertensive stroke-prone rats. In: Oxygen Transport to Tissue XVIII, ed. by Nemoto EM, La Manna P, Plenum Publ Co. New York, 1997, 365-368.
16. Ausprunk DH, Folkman J. Migration and proliferation of endo-thelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977;14:53-65.
17. Kojima M, Shiojima I, Yamazaki T, Komuro I,Yunzeng Z, Yin W, Mizuno T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994;89:2204-2211.
18. Price RJ, Owens GK, Skalak TC. Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation -Evidence that capillary arterialization proceeds from terminal arterioles. Circ Res 1994;75:520-527.
19. Monical PL, Owens GK, Murphy RA. Expression of myosin regulatory light-chain isoforms in normal and regulation of phosphorylation in smooth muscle. Am J Physiol. 1993;264:C1466-C1472.
20. Urata H, Healy B, Stwert RW, Bumpus FM, Hussain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990;66:883-890.
21. Zisman LS, Abraham WT, Meixel GE, Vamvakias BN, Quaife RA, Lowes BD, Roden RL, Peacock SJ, Groves BM, Raynolds MV, Bristow MR. Angiotensin II formation in the intact human heart. J Clin Invest 1995;95:1490-1498.